{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:09:54Z","timestamp":1793210994849,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.phrs.2024.107146","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T09:11:54Z","timestamp":1710580314000},"page":"107146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review"],"prefix":"10.1016","volume":"203","author":[{"given":"Michelangela","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiacomo","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaye","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Malyszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila-Yasmin","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mattace-Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Pepin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Perico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariadelina","family":"Simeoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Paolisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int. Suppl. (2011)"},{"issue":"8","key":"10.1016\/j.phrs.2024.107146_bib2","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/ndt\/gfs052","article-title":"Chronic kidney disease and life expectancy","volume":"27","author":"Turin","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"issue":"11","key":"10.1016\/j.phrs.2024.107146_bib3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1532-5415.2004.52508.x","article-title":"Cognitive impairment in chronic kidney disease","volume":"52","author":"Kurella","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.phrs.2024.107146_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jocn.2019.08.073","article-title":"Correlation between abnormal GSK3beta, beta Amyloid, total Tau, p-Tau 181 levels and neuropsychological assessment total scores in CKD patients with cognitive dysfunction: Impact of rHuEPO therapy","volume":"69","author":"Vinothkumar","year":"2019","journal-title":"J. Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2024.107146_bib5","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/ckj\/sfad241","article-title":"Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor","volume":"16","author":"Liabeuf","year":"2023","journal-title":"Clin. Kidney J."},{"issue":"12","key":"10.1016\/j.phrs.2024.107146_bib6","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1093\/ckj\/sfad239","article-title":"Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients","volume":"16","author":"Hafez","year":"2023","journal-title":"Clin. Kidney J."},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000356193","article-title":"Physiology and pharmacology of erythropoietin","volume":"40","author":"Jelkmann","year":"2013","journal-title":"Transfus. Med Hemother"},{"issue":"7","key":"10.1016\/j.phrs.2024.107146_bib8","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1161\/STROKEAHA.120.029680","article-title":"Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference","volume":"52","author":"Kelly","year":"2021","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13195-023-01356-w","article-title":"NeuroEPO plus (NeuralCIM((R))) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial","volume":"15","author":"Sosa","year":"2023","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.phrs.2024.107146_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.euroneuro.2023.12.004","article-title":"Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial","volume":"79","author":"Miskowiak","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107146_bib11","first-page":"263","article-title":"Brain protection by erythropoietin: a manifold task","volume":"23","author":"Rabie","year":"2008","journal-title":"Physiol. (Bethesda)"},{"issue":"9","key":"10.1016\/j.phrs.2024.107146_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4103\/1673-5374.215240","article-title":"Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor","volume":"12","author":"Hernandez","year":"2017","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.phrs.2024.107146_bib13","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1177\/089686089301302S131","article-title":"Effects of subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis","volume":"13 Suppl 2","author":"Di Paolo","year":"1993","journal-title":"Perit. Dial. Int"},{"issue":"9","key":"10.1016\/j.phrs.2024.107146_bib14","first-page":"1733","article-title":"Recombinant erythropoietin improves cognitive function in patients maintained on chronic ambulatory peritoneal dialysis","volume":"10","author":"Temple","year":"1995","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.phrs.2024.107146_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419871420","article-title":"Erythropoietin as a neuroprotective molecule: an overview of its therapeutic potential in neurodegenerative diseases","volume":"11","author":"Rey","year":"2019","journal-title":"ASN Neuro"},{"key":"10.1016\/j.phrs.2024.107146_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108670","article-title":"Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study","volume":"173","author":"Sardu","year":"2021","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.phrs.2024.107146_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122102","article-title":"EPO prevents neuroinflammation and relieves depression via JAK\/STAT signaling","volume":"333","author":"Luo","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib18","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1038\/s41467-023-40332-8","article-title":"Erythropoietin re-wires cognition-associated transcriptional networks","volume":"14","author":"Singh","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2024.107146_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1073191115602552","article-title":"The trail making test","volume":"24","author":"Llinas-Regla","year":"2017","journal-title":"Assessment"},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ki.1991.20","article-title":"rHuEPO treatment improves brain and cognitive function of anemic dialysis patients","volume":"39","author":"Marsh","year":"1991","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.phrs.2024.107146_bib21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ki.1990.229","article-title":"Improvement of brain function in hemodialysis patients treated with erythropoietin","volume":"38","author":"Grimm","year":"1990","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/1352458517690821","article-title":"Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis","volume":"23","author":"Benedict","year":"2017","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.phrs.2024.107146_bib23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1080\/13854046.2012.704073","article-title":"Using the Rey Auditory Verbal Learning Test (RAVLT) to differentiate alzheimer's dementia and behavioural variant fronto-temporal dementia","volume":"26","author":"Ricci","year":"2012","journal-title":"Clin. Neuropsychol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0028-3932(91)90092-M","article-title":"Cognitive function, mood and P3 latency: effects of the amelioration of anemia in dialysis patients","volume":"29","author":"Brown","year":"1991","journal-title":"Neuropsychologia"},{"issue":"3","key":"10.1016\/j.phrs.2024.107146_bib25","first-page":"CD010783","article-title":"Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)","volume":"2015","author":"Arevalo-Rodriguez","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2024.107146_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/23279095.2015.1135798","article-title":"Evolution of Wechsler's Memory Scales: Content and structural analysis","volume":"24","author":"Kent","year":"2017","journal-title":"Appl. Neuropsychol. Adult"},{"issue":"6","key":"10.1016\/j.phrs.2024.107146_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/13803390490509574","article-title":"Planning abilities and the Tower of London: is this task measuring a discrete cognitive function?","volume":"26","author":"Unterrainer","year":"2004","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-3999(03)00528-2","article-title":"Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients","volume":"57","author":"Lee","year":"2004","journal-title":"J. Psychosom. Res."},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib29","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/ki.1993.356","article-title":"Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failure","volume":"44","author":"Sagales","year":"1993","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.phrs.2024.107146_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1542-4758.2006.00107.x","article-title":"Effect of improvement in anemia on electroneurophysiological markers (P300) of cognitive dysfunction in chronic kidney disease","volume":"10","author":"Singh","year":"2006","journal-title":"Hemodial. Int"},{"issue":"6","key":"10.1016\/j.phrs.2024.107146_bib31","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0272-6386(99)70150-2","article-title":"Normalizing hematocrit in dialysis patients improves brain function","volume":"33","author":"Pickett","year":"1999","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1980-57642018dn12-010001","article-title":"On the use of the P300 as a tool for cognitive processing assessment in healthy aging: a review","volume":"12","author":"Pavarini","year":"2018","journal-title":"Dement Neuropsychol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107146_bib33","doi-asserted-by":"crossref","first-page":"M477","DOI":"10.1097\/00002480-199207000-00080","article-title":"Effects of uremia and dialysis on brain electrophysiology after recombinant erythropoietin treatment","volume":"38","author":"Di Paolo","year":"1992","journal-title":"ASAIO J."},{"issue":"4","key":"10.1016\/j.phrs.2024.107146_bib34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0272-6386(95)90122-1","article-title":"Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients","volume":"25","author":"Revicki","year":"1995","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"10.1016\/j.phrs.2024.107146_bib35","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1185\/030079907X242502","article-title":"Association of anemia correction with health related quality of life in patients not on dialysis","volume":"23","author":"Alexander","year":"2007","journal-title":"Curr. Med. Res Opin."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib36","first-page":"40","article-title":"The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Med.\u00a0Care"},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.V75763","article-title":"The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients","volume":"7","author":"Beusterien","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2024.107146_bib38","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1185\/030079908X280653","article-title":"The association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysis","volume":"24","author":"Abu-Alfa","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.phrs.2024.107146_bib39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2215\/CJN.06450710","article-title":"Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial","volume":"6","author":"Lewis","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11136-007-9176-6","article-title":"Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis","volume":"16","author":"Plantinga","year":"2007","journal-title":"Qual. Life Res."},{"issue":"20","key":"10.1016\/j.phrs.2024.107146_bib41","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.phrs.2024.107146_bib42","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phrs.2024.107146_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0272-6386(89)80148-9","article-title":"Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients","volume":"14","author":"Wolcott","year":"1989","journal-title":"Am. J. Kidney Dis."},{"issue":"17","key":"10.1016\/j.phrs.2024.107146_bib44","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.18632\/aging.102227","article-title":"Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study","volume":"11","author":"Hung","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.freeradbiomed.2007.05.037","article-title":"Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment","volume":"43","author":"Butterfield","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"41","key":"10.1016\/j.phrs.2024.107146_bib46","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential","volume":"29","author":"Vassar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107146_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biopha.2018.05.028","article-title":"Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and Abeta expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer's disease: a pilot study","volume":"104","author":"G","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107146_bib48","first-page":"S141","article-title":"GSK3 and tau: two convergence points in Alzheimer's disease","volume":"33 Suppl 1","author":"Hernandez","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2024.107146_bib49","doi-asserted-by":"crossref","first-page":"1077302","DOI":"10.3389\/fragi.2022.1077302","article-title":"Impact of impaired cerebral blood flow autoregulation on cognitive impairment","volume":"3","author":"Wang","year":"2022","journal-title":"Front. Aging"},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer's disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2024.107146_bib51","first-page":"1238","article-title":"A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET","volume":"36","author":"Minoshima","year":"1995","journal-title":"J. Nucl. Med."},{"issue":"5 Pt 2","key":"10.1016\/j.phrs.2024.107146_bib52","first-page":"F737","article-title":"CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO","volume":"262","author":"Hirakata","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107146_bib53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1152\/japplphysiol.00234.2010","article-title":"Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men","volume":"109","author":"Rasmussen","year":"2010","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.phrs.2024.107146_bib54","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2024.107146_bib55","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-021-01170-y","article-title":"Vascular Cognitive Impairment (VCI)","volume":"19","author":"Rundek","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2337\/diacare.23.5.658","article-title":"Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients","volume":"23","author":"Marfella","year":"2000","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.phrs.2024.107146_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2008.05.004","article-title":"Kidney function and cognitive impairment in US adults: the reasons for geographic and racial differences in stroke (REGARDS) Study","volume":"52","author":"Kurella Tamura","year":"2008","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.phrs.2024.107146_bib59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/01.wnl.0000225182.15532.40","article-title":"Cognitive impairment in hemodialysis patients is common","volume":"67","author":"Murray","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.phrs.2024.107146_bib60","doi-asserted-by":"crossref","first-page":"c247","DOI":"10.1159\/000317206","article-title":"Cognitive profile of chronic kidney disease and hemodialysis patients without dementia","volume":"116","author":"Post","year":"2010","journal-title":"Nephron Clin. Pract."},{"issue":"7","key":"10.1016\/j.phrs.2024.107146_bib61","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1097\/01.ASN.0000131529.60019.FA","article-title":"Moderate renal impairment and risk of dementia among older adults: the cardiovascular health cognition study","volume":"15","author":"Seliger","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1590\/2175-8239-jbn-2018-0033","article-title":"The specific impact of uremic toxins upon cognitive domains: a review","volume":"41","author":"Franco","year":"2019","journal-title":"J. Bras. Nefrol."},{"key":"10.1016\/j.phrs.2024.107146_bib63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fcvm.2020.00096","article-title":"Cerebrovascular disease and cognition in chronic kidney disease patients","volume":"7","author":"Miglinas","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.phrs.2024.107146_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.0b013e318225aaa9","article-title":"Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis","volume":"77","author":"Shah","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.phrs.2024.107146_bib65","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neurobiolaging.2005.02.007","article-title":"Anaemia increases the risk of dementia in cognitively intact elderly","volume":"27","author":"Atti","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.phrs.2024.107146_bib66","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1073\/pnas.1031753100","article-title":"Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo","volume":"100","author":"Erbayraktar","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.phrs.2024.107146_bib67","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1460-9568.1996.tb01252.x","article-title":"Erythropoietin gene expression in human, monkey and murine brain","volume":"8","author":"Marti","year":"1996","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107146_bib68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s004060170038","article-title":"Erythropoietin--a novel concept for neuroprotection","volume":"251","author":"Siren","year":"2001","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.mp.4001442","article-title":"Erythropoietin: a candidate compound for neuroprotection in schizophrenia","volume":"9","author":"Ehrenreich","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107146_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106448","article-title":"Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes","volume":"184","author":"Marfella","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.phrs.2024.107146_bib71","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1007\/s12035-017-0568-5","article-title":"Erythropoietin rescues memory impairment in a rat model of chronic cerebral hypoperfusion via the EPO-R\/JAK2\/STAT5\/PI3K\/Akt\/GSK-3beta pathway","volume":"55","author":"Ma","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.phrs.2024.107146_bib72","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1007\/s12035-015-9438-1","article-title":"Erythropoietin attenuates the memory deficits in aging rats by rescuing the oxidative stress and inflammation and promoting BDNF releasing","volume":"53","author":"Jia","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17219\/acem\/61044","article-title":"Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats","volume":"26","author":"Cevik","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-160500","article-title":"An intranasal formulation of erythropoietin (Neuro-EPO) prevents memory deficits and amyloid toxicity in the APPSwe transgenic mouse model of alzheimer's disease","volume":"55","author":"Rodriguez Cruz","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.phrs.2024.107146_bib75","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/156720205774962683","article-title":"Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity","volume":"2","author":"Chong","year":"2005","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.phrs.2024.107146_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110614","article-title":"Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice","volume":"106","author":"Yan","year":"2023","journal-title":"Cell Signal."},{"issue":"3","key":"10.1016\/j.phrs.2024.107146_bib77","first-page":"147","article-title":"Human recombinant erythropoietin reduces sensorimotor dysfunction and cognitive impairment in rat models of chronic kidney disease","volume":"35","author":"Reza-Zaldivar","year":"2020","journal-title":"Neurol. (Engl. Ed. )"},{"issue":"6","key":"10.1016\/j.phrs.2024.107146_bib78","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/cen.12446","article-title":"Insulin-like growth factor-II: its role in metabolic and endocrine disease","volume":"80","author":"Livingstone","year":"2014","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.phrs.2024.107146_bib79","article-title":"The role of brain-derived neurotrophic factor in epileptogenesis: an update","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.phrs.2024.107146_bib80","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2024.107146_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1010693","article-title":"Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: a brief summary","volume":"9","author":"Mascolo","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.phrs.2024.107146_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75838-4","article-title":"Hypoxia-inducible factor-2alpha is crucial for proper brain development","volume":"10","author":"Kleszka","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107146_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837249","article-title":"Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases","volume":"13","author":"Miao","year":"2022","journal-title":"Front Pharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T03:01:49Z","timestamp":1714273309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":83,"alternative-id":["S1043661824000902"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107146","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107146"}}